Chromate(3-), bis[2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]benzoato(3-)]-, hydrogen, compd. with N-cyclohexylcyclohexanamine (1:3:2)
-
Chromate(3-), bis[2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]benzoato(3-)]-, hydrogen, compd. with N-cyclohexylcyclohexanamine (1:3:2)
structure -
-
CAS No:
63982-58-1
-
Formula:
C34H22CrN8O12S2.2C12H23N.3H
-
Chemical Name:
Chromate(3-), bis[2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]benzoato(3-)]-, hydrogen, compd. with N-cyclohexylcyclohexanamine (1:3:2)
-
Synonyms:
Chromate(3-),bis[2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]benzoato(3-)]-,hydrogen,compd. with N-cyclohexylcyclohexanamine (1:3:2);Chromate(3-),bis[2-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]azo]benzoato(3-)]-,trihydrogen,compd. with N-cyclohexylcyclohexanamine (1:2);Benzoic acid,2-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]azo]-,chromium complex
-
CAS No:
Chromate(3-), bis[2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]benzoato(3-)]-, hydrogen, compd. with N-cyclohexylcyclohexanamine (1:3:2) Basic Attributes
1216.4 g/mol
1215.409940 g/mol
264-591-9
Chromate(3-), bis[2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]benzoato(3-)]-, hydrogen, compd. with N-cyclohexylcyclohexanamine (1:3:2) Use and Manufacturing
Chromate(3-), bis[2-[2-[4,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-1H-pyrazol-4-yl]diazenyl]benzoato(3-)]-, hydrogen, compd. with N-cyclohexylcyclohexanamine (1:3:2): INACTIVE
Computed Properties
Molecular Weight:1216.4
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:20
Rotatable Bond Count:10
Exact Mass:1215.409940
Monoisotopic Mass:1215.409940
Topological Polar Surface Area:367
Heavy Atom Count:83
Complexity:786
Covalently-Bonded Unit Count:8
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Cuprate(4-), bis[8-hydroxy-5,7-quinolinedisulfonato(3-)-κN1,κO8]-, hydrogen, compd. with N-ethylethanamine (1:4:4)
13007-93-7
-
L-Isoleucine, N-[[1-(3,5-dimethoxyphenyl)-1-methylethoxy]carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
39508-06-0
-
L-Alanine, N-[[1-(3,5-dimethoxyphenyl)-1-methylethoxy]carbonyl]-3-[(1,1-dimethylethyl)dithio]-, compd. with N-cyclohexylcyclohexanamine (1:1)
39508-12-8
-
L-Serine, N-[[1-(3,5-dimethoxyphenyl)-1-methylethoxy]carbonyl]-O-(1,1-dimethylethyl)-, compd. with N-cyclohexylcyclohexanamine (1:1) Formula
39508-10-6
-
Cobaltate(1-), bis[N-[7-(hydroxy-κO)-8-[2-[2-(hydroxy-κO)-5-[(methylamino)sulfonyl]phenyl]diazenyl-κN1]-1-naphthalenyl]acetamidato(2-)]-, hydrogen, compd. with 2-propanamine (1:1:1) Formula
71839-76-4
-
Phosphorodithioic acid, O,O-bis(1-methylpropyl) ester, compd. with N-cyclohexylcyclohexanamine (1:1) Formula
70682-65-4
-
Platinate (Pt(OH)62-), (OC-6-11)-, hydrogen, compd. with 2-aminoethanol (1:2:2) Structure
68133-90-4
-
L-Glutamine, N2-[(2-nitrophenyl)thio]-, compd. with N-cyclohexylcyclohexanamine (1:1) Structure
64143-47-1
-
What is L-Alanine, N-[(ethenyloxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
39897-21-7
-
What is Cobaltate(1-), bis[4-(hydroxy-κO)-3-[2-[2-(hydroxy-κO)-1-naphthalenyl]diazenyl-κN1]benzenesulfonamidato(2-)]-, hydrogen, compd. with 3-[(2-ethylhexyl)oxy]-1-propanamine (1:1:1)
84912-04-9
Request for Quotation